Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Atacand 16mg


Contraindicated

Not recommended
Manque de données
Atacand 16mg :
Type Medicine Withdrawn
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory AstraZeneca
Responsible Party AstraZeneca AG
Origin Switzerland
Manufacturer AstraZeneca AB
Origin Sweden
ATC C09CA06

Your comment will appear shortly after approval

Atacand 16mg :

Revision Date :


Effect Frequency
Agranulocytosis Very rare
ALT increased Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Arthralgia (Pain joint) (Joint ache) Very rare
Back pain Very rare
Blood sodium decreased Common
Blood uric acid increased Common
Cephalea Common
Haemoglobin decreased Common
Hepatic dysfunction Very rare
Hepatic enzyme increased Very rare
Hepatitis Very rare
Hyperkalaemia Common
Hyponatraemia (Hyponatremia) Very rare
Hypotension Common
Kidney function abnormal Very rare
Leucopenia (Leukopenia) Very rare
Lightheadedness Common
Myalgia Very rare
Nausea Very rare
Neutropenia Very rare
Pruritus Very rare
Renal insufficiency Common
Respiratory tract infection Common
Serum creatinine increased Common
Skin Eruption Very rare
Urticaria Very rare
Vertigo Common

Different Units By MoH Code

Revision Date : 01/06/2007

Revision Date : 01/03/2020

Atacand 16mg  MoH 11220 :
Form Tablet
Packaging Blisters
Package Size Box of 28
Strength 16mg
NSSF ✘
Quarantine ✘
Reg. Number 87321/1
Submission date 2021
Registration Year 01/08/2023
Withdrawn Date 06/05/2025


NB : Double Registration in 2023 with same manufacturer

Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info